Form 15-12G Nascent Biotech Inc.

 

 

		OMB APPROVAL
	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549	OMB Number:  3235-0167 Expires:  August 31, 2027 Estimated average burden hours per response................. 1.50

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER

SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION

OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number 000-55299

 

Nascent Biotech Inc.

(Exact name of registrant as specified in its charter)

 

NASCENT BIOTECH INC  631 US Hwy 1 Suite 407, North Palm Beach, FL 33408

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock

(Title of each class of securities covered by this Form)

 

___________________________________________________________________________________________

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

	Rule 12g-4(a)(1)	☒
	Rule 12g-4(a)(2)	☐
	Rule 12h-3(b)(1)(I)	☐
	Rule 12h-3(b)(1)(ii)	☐
	Rule 15d-6	☐
	Rule 15d-22(b)	☐

 

Approximate number of holders of record as of the certification or notice date: 163

 

Pursuant to the requirements of the Securities Exchange Act of 1934 (Nascent Biotech Inc has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: March 31, 2025	By:  /s/ Lowell Holden
	Title: CFO

 

SEC 2069 (08-11)

Potential persons who are to respond to the collection of information contained in this Form are not required to respond unless the Form displays a currently valid OMB control number.

 

 

Board of Governors of the Federal Reserve System

OMB Number 7100-0091

Approval expires February 28, 2026

                

 

Instruction: This form is required by Rules 12g-4, 12h-3, 15d-6 and 15d-22 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.

 

2 of 2

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Dell Technologies Introduces XPS Googlebook: The First XPS Laptop Built for Gemini Intelligence
• Recommendable Launches AI Visibility Service Helping UK Businesses Get Recommended by ChatGPT, Gemini and Google AI Overviews
• From GABA to Goji: A Scientific Benchmark for Functional Ingredients in Asia Takes Shape in Zhangzhou